Marsh, Laura

Laura Marsh, M.D. Associate Professor Director, Parkinson's and Related Disorders Clinic Main Office Address Phipps 300 The Johns Hopkins Hospital 600 North Wolfe Street Baltimore, MD 21287 Phone: 410-502-6945 Fax: 410-614-3676 E-mail: lmarsh@jhmi.edu

Education and Government Service

Professional Interests

Laura Marsh, M.D. is an Associate Professor in the Department of Psychiatry and Behavioral Sciences and in the Department of Neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland. She directs and is the principal investigator of the Clinical Core Research Program of the NIH-funded Morris K. Udall Parkinson's Disease Research Center of Excellence at Johns Hopkins (P.I., Ted Dawson, M.D., Ph.D.).  In addition to her affiliation with the Division of Psychiatric Neuroimaging, Dr. Marsh is an Attending Psychiatrist with the Geriatric Psychiatry and Neuropsychiatry Division at the Johns Hopkins University School of Medicine and a faculty member of the Johns Hopkins Parkinson’s Disease and Movement Disorders Center, which has been designated a Center of Excellence by the National Parkinson Foundation. Dr. Marsh is also a member of the scientific advisory boards for the American Parkinson’s Disease Foundation, the Parkinson’s Study Group,  and the Leeza Gibbons Memory Foundation.

Dr. Marsh’s clinical and academic research interests focus on Neuropsychiatry and she has specific expertise in the neuropsychiatric aspects of Parkinson’s disease and of epilepsy. Her current work focuses on the psychiatric aspects of Parkinson’s disease, with her primary research and outreach efforts aimed at improving the recognition and treatment of psychiatric and cognitive disturbances in Parkinson’s disease.  She is also investigating the relationships between motor, psychiatric, and cognitive aspects of PD and their relationship to the longitudinal course of the disease.

Click here to learn more about Dr. Marsh's research

Selected Publications

Leroi I, Brandt J, Reich SG, Grill S, Thompson R, Marsh L. Randomized placebo-controlled trial of donepezil for cognitive impairment in Parkinson’s disease. International Journal of Geriatric Psychiatry 2004; 19:1-8

Marsh L, Williams JR, Rocco M, Grill S, Munro C, Dawson TM. Psychiatric co-morbidities in patients with Parkinson’s disease and psychosis. Neurology 2004; 63: 293-300.

Pletnikova O, West N, Lee M, Rudow G, Dawson T, Marsh L, Troncoso J. ?-synuclein lesions of Lewy body disease are enhanced by Aß deposition. Neurobiology of Aging 2005; 26(8):1183-1192.

.Leroi I, Collins D, Marsh L. Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson’s disease: A critical review. Journal of Neurological Sciences 2006; 248:104-114.

Marsh L, McDonald WM, Cummings J, Ravina B. Provisional Diagnostic Criteria for Depression in Parkinson’s Disease: Report of an NINDS/NIMH Work Group. Movement Disorders 2006; 21(2):148-58.

Pontone G, Williams JR, Bassett SS, Marsh L. Clinical features of impulse control disorders in Parkinson’s disease. Neurology  2006; 67(7): 1258-1261

Ravina B, Marder K, Fernandez  H, Friedman J, McDonald W, Murphy D, Aarsland D, Babcock D, Cummings J, Endicott J,Factor S, Galpern W, Lees A, Marsh L, Stacy M, Gwinn-Hardy K, Voon V, Goetz C.  Diagnostic Criteria for Psychosis in Parkinson’s disease: Report of an NINDS/NIMH Work Group. Movement Disorders , In Press.